Exhibit 99.1

    ZOLL Medical Completes Acquisition of Business of Lifecor, Inc.

    CHELMSFORD, Mass.--(BUSINESS WIRE)--April 10, 2006--ZOLL Medical
Corporation (NASDAQ: ZOLL), a manufacturer of resuscitation devices
and related software solutions, today announced that it had completed
the acquisition of the assets of Lifecor, Inc., a privately owned
medical equipment company that designs, manufactures and markets a
wearable external defibrillator system. ZOLL had announced on March
22, 2006 that it had exercised a previously granted option to acquire
the assets.
    As a result of the transaction, ZOLL acquired Lifecor's assets and
business, assumed Lifecor's outstanding debt of approximately $5.8
million (plus an additional $3.0 million owed to ZOLL), and also
assumed certain stated liabilities of approximately $1.5 million.
Additional consideration will be in the form of earn-out payments to
Lifecor based upon future revenue growth of the acquired business over
a five-year period.
    ZOLL will operate the Lifecor business through its ZOLL Lifecor
subsidiary, based in Pittsburgh, Pennsylvania.
    The principal acquisition agreements between ZOLL and Lifecor were
filed by ZOLL with the Securities and Exchange Commission on September
20, 2005 as exhibits to a current report on Form 8-K.

    About ZOLL Medical Corporation

    ZOLL Medical Corporation is committed to developing technologies
that help advance the practice of resuscitation. With products for
pacing, defibrillation, circulation, ventilation, and fluid
resuscitation, ZOLL provides a comprehensive set of technologies that
help clinicians, EMS professionals, and lay rescuers resuscitate
sudden cardiac arrest or trauma victims. ZOLL also designs and markets
software that automates the documentation and management of both
clinical and non-clinical information.

    ZOLL markets and sells its products in more than 140 countries.
The Company has direct operations, distributor networks, and business
partners throughout the U.S., Canada, Latin America, Europe, the
Middle East, Asia, and Australia. For more information, visit
www.zoll.com or call +1 (978) 421-9655.

    Certain statements contained in this press release regarding
matters that are not historical facts are "forward-looking" statements
(as defined in the Private Securities Litigation Reform Act of 1995).
Because such statements are subject to risks and uncertainties, actual
results may differ materially from those expressed or implied by such
forward-looking statements. Factors that could cause actual results to
differ materially from those expressed or implied by such
forward-looking statements include, but are not limited to, ZOLL's
ability to compete; acceptance of its resuscitation products; changes
in regulations affecting the healthcare industry; general economic
conditions; and those other factors discussed in the section entitled
"Risk Factors" in ZOLL's Quarterly Report on Form 10-Q, which was
filed with the SEC on February 10, 2006.

    (C) 2006 ZOLL Medical Corporation. All rights reserved. 269 Mill
Road, Chelmsford, MA 01824-4105. ZOLL is a registered trademark of
ZOLL Medical Corporation. All product names are the property of their
respective owners.



    CONTACT: Investor Contact:
             ZOLL Medical Corporation
             A. Ernest Whiton, 978-421-9655
             Chief Financial Officer
             or
             Media Contact:
             Robert Minicucci, 978-421-9832
             Corporate Communications Manager
             rminicucci@zoll.com